BioMarin Pharmaceutical Inc. buy Wolfe Research
Start price
16.03.26
/
50%
€50.46
Target price
16.03.27
-
Performance (%)
-7.85%
Price
10.04.26
€46.50
Summary
This prediction is currently active. With a performance of -7.85%, the BUY prediction by Wolfe_Research is trending in the wrong direction. This prediction currently runs until 16.03.27. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| BioMarin Pharmaceutical Inc. | -3.367% |
| iShares Core DAX® | 2.554% |
| iShares Nasdaq 100 | 2.742% |
| iShares Nikkei 225® | 6.584% |
| iShares S&P 500 | 1.930% |
Comments by Wolfe_Research for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) had its "outperform" rating reaffirmed by Wolfe Research.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.93
15.07.25
15.07.25
€81.42
15.07.26
15.07.26
-6.87%
10.04.26
10.04.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€60.78
15.11.24
15.11.24
€89.95
15.11.25
15.11.25
-22.26%
16.11.25
16.11.25